semaglutide class action in louisiana glp-1 gastrointestinal obstruction law firm gastric intestinal gastric intestinal obstruction attorney in glp-1 vomiting attorney in louisiana

Phase 2 obesity trial: Escalating weekly doses from 1 mg to 12 mg over 48 weeks

Our program provides clinically proven weight loss benefits: Significant Weight Reduction : Patients typically achieve 15-25% or more of their body weight loss, with many experiencing even greater results when following the complete program protocol

GLP-1 medications slow gastric emptying, which means raw, high-fiber vegetables can sit in your stomach longer and cause bloating, gas, or discomfort

Used with lifestyle changes, 2.4 mg of subcutaneous SGT weekly resulted in a mean 10% to 15% weight loss (10 to 15 kg) over 68 weeks versus 2% to 3% (3 to 4 kg) with placebo (PC)